Novolog Pharm-Up 1966 Ltd (NVLG) — Cash Flow Reinvestment Rate
Novolog Pharm-Up 1966 Ltd (NVLG) has a Cash Flow Reinvestment Rate of 1.41x as of September 2025, reinvesting ILA21.78 Million (capex ILA21.78 Million ) from operating cash flow of ILA15.42 Million. Explore capital reinvestment ratio of Novolog Pharm-Up 1966 Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Novolog Pharm-Up 1966 Ltd Cash Flow Reinvestment Rate (2014–2024)
Historical reinvestment intensity for Novolog Pharm-Up 1966 Ltd across 11 annual periods. Also explore NVLG asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Novolog Pharm-Up 1966 Ltd (2014–2024)
Year-by-year capital reinvestment analysis for Novolog Pharm-Up 1966 Ltd. For live market cap and broader valuation context, see Novolog Pharm-Up 1966 Ltd (NVLG) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (ILA) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.37x | ILA58.74 Million | ILA158.52 Million | ILA58.74 Million | ▲ +0.1% |
| 2023 | 0.37x | ILA74.05 Million | ILA200.01 Million | ILA70.95 Million | ▼ -39.7% |
| 2022 | 0.61x | ILA81.42 Million | ILA132.65 Million | ILA69.49 Million | ▼ -10.8% |
| 2021 | 0.69x | ILA57.35 Million | ILA83.39 Million | ILA30.64 Million | ▼ -23.1% |
| 2020 | 0.89x | ILA52.33 Million | ILA58.48 Million | ILA25.61 Million | ▲ +75.5% |
| 2019 | 0.51x | ILA51.73 Million | ILA101.45 Million | ILA25.01 Million | ▼ -59.0% |
| 2018 | 1.24x | ILA29.77 Million | ILA23.96 Million | ILA29.27 Million | ▲ +203.2% |
| 2017 | 0.41x | ILA35.39 Million | ILA86.37 Million | ILA34.89 Million | ▼ -83.1% |
| 2016 | 2.42x | ILA49.06 Million | ILA20.28 Million | ILA13.32 Million | ▲ +2726.7% |
| 2015 | 0.09x | ILA12.00 Million | ILA140.29 Million | ILA11.50 Million | ▲ +402.8% |
| 2014 | 0.02x | ILA2.73 Million | ILA160.59 Million | ILA2.73 Million | — |